Jyoti Dixit

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Gestational Age

Health Insurance

Metastatic Breast Cancer

Replacement Therapy

Top Venues

JCO global oncology

Applied health economics and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Nidhi Gupta, Prerika Nehra, Akashdeep Singh Chauhan, Nikita Mehra, Ashish Singh, Manjunath Nookala Krishnamurthy, Kavitha Rajsekhar, Jayachandran Perumal Kalaiyarasi, Partha Sarathi Roy, Prabhat Singh Malik, Anisha Mathew, Pankaj Malhotra, Amal Chandra Kataki, Jyoti Dixit, Sudeep Gupta, Lalit Kumar, Shankar Prinja
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis. JCO global oncology 8 (2022)
Nidhi Gupta, Dharna Gupta, Jyoti Dixit, Nikita Mehra, Ashish Singh, Manjunath Nookala Krishnamurthy, Sushmita Ghoshal, Kavitha Rajsekhar, Jayachandran Perumal Kalaiyarasi, Partha Sarathi Roy, Prabhat Singh Malik, Anisha Mathew, Pankaj Malhotra, Sudeep Gupta, Lalit Kumar, Amal Kataki, Shankar Prinja
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. Applied health economics and health policy 20 (4) (2022)